Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arribas, R.
Right arrow Articles by Peinado, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arribas, R.
Right arrow Articles by Peinado, M. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 15, 3230-3240, Copyright © 1997 by American Society of Clinical Oncology


ARTICLES

Assessment of genomic damage in colorectal cancer by DNA fingerprinting: prognostic applications

R Arribas, G Capella, S Tortola, L Masramon, WE Grizzle, M Perucho and MA Peinado
Institut de Recerca Oncologica, Hospital Duran i Reynals, Barcelona, Spain.

PURPOSE: Here we evaluate the prognostic significance of the relative value of genomic damage assessed by DNA fingerprinting in colorectal cancer. MATERIALS AND METHODS: Sixty-three tumor and paired normal mucosa samples were included in the study. Genomic damage was assessed by comparative analysis of paired normal and tumor tissue DNA fingerprints by the arbitrarily primed polymerase chain reaction (AP- PCR). Decreases and increases of intensity in bands were computed and referred to the total number of visualized bands per case. An index reflecting the genomic damage fraction (GDF), with separated values for losses and gains, was obtained for each tumor. This index was used to determine molecular and clinicopathologic correlates after exclusion of eight cases displaying microsatellite instability. RESULTS: Fifty-five cases were considered for the statistical analysis. The average fraction of altered bands per tumor was 0.287+/-0.121. When losses and gains were computed separately, the average fraction of changes was 0.126+/-0.113 and 0.161+/-0.120, respectively. Tumors lacking a ras mutation showed an increased GDF, primarily because of a higher fraction of gains. Tumors that were at advanced Dukes' stages and that were poorly differentiated also displayed a higher GDF. Finally, disease-free survival was significantly diminished in tumors with a GDF greater than 0.314 (P < .001). The prognostic significance of the GDF was independent of Dukes' stage (Cox multivariate analysis, P = .005). CONCLUSION: The degree of genomic damage assessed by unbiased DNA fingerprinting correlates with genotypic, phenotypic, and clinical variables in colorectal carcinoma and may be useful in assessing prognosis in colorectal cancer.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. R. Mehta, K. Nakao, M. B. Zuraek, D. T. Ruan, E. K. Bergsland, A. P. Venook, D. H. Moore, T. A. Tokuyasu, A. N. Jain, R. S. Warren, et al.
Fractional Genomic Alteration Detected by Array-Based Comparative Genomic Hybridization Independently Predicts Survival after Hepatic Resection for Metastatic Colorectal Cancer
Clin. Cancer Res., March 1, 2005; 11(5): 1791 - 1797.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Gu, L. Espana, O. Mendez, A. Torregrosa, and A. Sierra
Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus
Carcinogenesis, December 1, 2004; 25(12): 2293 - 2301.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R.-A. Risques, V. Moreno, M. Ribas, E. Marcuello, G. Capella, and M. A. Peinado
Genetic Pathways and Genome-Wide Determinants of Clinical Outcome in Colorectal Cancer
Cancer Res., November 1, 2003; 63(21): 7206 - 7214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Tarafa, E. Prat, R.-A. Risques, S. Gonzalez, J. Camps, M. Grau, E. Guino, V. Moreno, M. Esteller, J. G. Herman, et al.
Common Genetic Evolutionary Pathways in Familial Adenomatous Polyposis Tumors
Cancer Res., September 15, 2003; 63(18): 5731 - 5737.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. M. Huycke, V. Abrams, and D. R. Moore
Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA
Carcinogenesis, March 1, 2002; 23(3): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
I. Gonzalez-Garcia, V. Moreno, M. Navarro, J. Marti-Rague, E. Marcuello, C. Benasco, O. Campos, G. Capella, and M. A. Peinado
Standardized Approach for Microsatellite Instability Detection in Colorectal Carcinomas
J Natl Cancer Inst, April 5, 2000; 92(7): 544 - 549.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. L. Stoler, N. Chen, M. Basik, M. S. Kahlenberg, M. A. Rodriguez-Bigas, N. J. Petrelli, and G. R. Anderson
The onset and extent of genomic instability in sporadic colorectal tumor progression
PNAS, December 21, 1999; 96(26): 15121 - 15126.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Malkhosyan, J. Yasuda, J. L. Soto, T. Sekiya, J. Yokota, and M. Perucho
Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting
PNAS, August 18, 1998; 95(17): 10170 - 10175.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1997 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online